Measuring the severity of topical 5-fluorouracil toxicity

J Cutan Med Surg. 2014 Jul-Aug;18(4):229-35. doi: 10.2310/7750.2013.13143.

Abstract

Background: Topical 5% 5-fluorouracil (5-FU) is known to cause toxicity, such as erythema, pain, and crusting/erosions.

Objectives: We sought to develop a scale to measure this toxicity and test the scale for reliability.

Methods: A scale was developed involving four parameters: erythema severity, percentage of face involved in erythema, crusting/erosions severity, and percentage of face involved in crusting/erosions. Thirteen raters graded 99 sets of photographs from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial using these parameters.

Results: Intraclass correlation overall for 13 raters was 0.82 (95% CI 0.77-0.86). There was no statistically significant trend in reliability by level of training in dermatology.

Conclusions: This scale is a reliable method of evaluating the severity of toxicity from topical 5-fluorouracil and can be used by dermatologists and nondermatologists alike.

Publication types

  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / adverse effects*
  • Carcinoma, Basal Cell / drug therapy
  • Carcinoma, Squamous Cell / drug therapy
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology*
  • Erythema / chemically induced
  • Erythema / pathology*
  • Facial Dermatoses / chemically induced
  • Facial Dermatoses / pathology*
  • Female
  • Fluorouracil / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Observer Variation
  • Reproducibility of Results
  • Severity of Illness Index
  • Skin Neoplasms / drug therapy*

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil